Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lavender Bina Cendikia Tbk. (BMBL) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Lavender Bina Cendikia Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Lavender Bina Cendikia Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Lavender Bina Cendikia Tbk. trades at Rp30 (market cap 30.9B, 2.96M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 10.1× Lavender Bina Cendikia Tbk.'s market cap, and Lavender Bina Cendikia Tbk. is more actively traded (2.96M versus 963.6K). Which is the better fit depends on your goals.

BMBLDGNS
Market Cap
30.9B310.75B
Volume
2.96M963.6K
Lot
29.64K9.64K
Turnover
88.75M217.67M
Average Price
29.94225.89
Value
88.75M217.67M
Indicative Equilibrium Price
30226
Indicative Equilibrium Volume
11K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMBL
View details
DGNS
View details

About Lavender Bina Cendikia Tbk.

PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.

Read more on BMBL

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS